source:[1] Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025) - ts2.tech (https://ts2.tech/en/healthcare-pharma-giants- ...)[2] Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025) - ts2.tech (https://ts2.tech/en/eli-lilly-stock-lly-news- ...)[3] US Treasury Bonds Forecast for December 2025: Fed Rate Cut, Delayed Jobs & CPI Data, and Auction Supply Set Up a Volatile Finish - ts2.tech (https://ts2.tech/en/us-treasury-bonds-forecas ...)